CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 25 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $66,000 | -87.0% | 82,765 | -84.4% | 0.00% | -100.0% |
Q2 2018 | $508,000 | +1351.4% | 530,187 | +3153.9% | 0.00% | – |
Q3 2017 | $35,000 | -82.9% | 16,294 | -36.9% | 0.00% | – |
Q4 2015 | $205,000 | -60.3% | 25,830 | -59.6% | 0.00% | -100.0% |
Q3 2015 | $517,000 | -43.4% | 63,957 | -14.5% | 0.00% | -50.0% |
Q2 2015 | $913,000 | – | 74,791 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,857,667 | $10,573,000 | 10.68% |
Clarus Ventures, LLC | 2,752,488 | $10,184,000 | 8.91% |
Rhenman & Partners Asset Management AB | 345,100 | $1,277,000 | 0.23% |
SPHERA FUNDS MANAGEMENT LTD. | 203,243 | $752,000 | 0.20% |
Camber Capital Management LP | 1,000,000 | $3,700,000 | 0.18% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 643,580 | $2,381,000 | 0.09% |
FT Options LLC | 15,059 | $56,000 | 0.05% |
FRED ALGER MANAGEMENT, LLC | 86,782 | $321,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 27,700 | $102,000 | 0.00% |
FIRST NEW YORK SECURITIES LLC /NY | 750 | $2,775,000 | 0.00% |